Distinct genomic instabilities associated with deficiencies in or the FANCD2 monoubiquitination pathway

April 19th, 2005

John Hinz Lawrence Livermore National Laboratory Livermore, CA Summary:

Homologous Recombination Fanconi anemia

Genome stability

Model discussion Homologous Recombination repair: Repairing DSBs & restarting replication forks

XRCC3 51 BRCA2 XRCC2 51 51C 51D 51 51 5151B 51 51 Fanconi anemia complementation groups:

FancA, B, C, D1, D2, E, F, G, L

51 BRCA2 51 5151 51 51 51 FA in the cell

A BA GG Ub C C B FF D2 E L E L A G Ub C B F D2 E L BRCA1 51 BRCA2 51 5151 51 51 51 Construction of a FancG knockout

AA8AA8 FancG

KO40KO40 FancGNEO gene

FancGNEO gene BP6BP6 FancG gene BAC Construction of a Rad51D knockout AA8AA8 Rad51D gene Rad51D gene

51D1Lox51D1Lox RadRad51DNEO gene51D gene RadRad51DPURO gene51D gene

51D151D1 Rad gene Rad gene

51D1.351D1.3 Rad51D gene BAC Colony Formation Assays: Cross-link sensitivity

1.0 AA8AA8 KO40KO40 ((fancgfancg)) BP6BP6 Fraction survival

0.1 0.0 1.0 2.0 3.0 4.0 5.0 Mitomycin C (µM) 1.0 AA8AA8 51D1Lox51D1Lox

51D151D1 ((rad51drad51d)) irs1SFirs1SF ((xrcc3xrcc3))

51D1.351D1.3 0.1 KO40KO40 ((fancgfancg)) 0.1 1.0 Mitomycin C (µM) Gene Amplification

Importance of DSBs

Amplifications drive tumorgenesis Amplification Rate at dhfr (units = mutations/dhfr locus/generation)

Cell line Rate (x 10-6) AA8AA8 8.8 ± 0.2 KO40KO40 ((fancgfancg)) 27 ± 2 ( ~3x) BP6BP6 9 ± 2 51D1Lox51D1Lox 7 ± 4 51D151D1 ((rad51drad51d)) 95 ± 4 ( ~10x) irs1SFirs1SF ((xrcc3xrcc3)) 60 ± 14 ( ~7x) 51D1.351D1.3 3 ± 2 Measuring mutation rate at hprt

guanine GMP GTP HPRT 66--thioguaninethioguanine TOXICTOXIC

hprt

Large deletions/rearrangements not detectable FancG mutant has decreased mutation rate

Mutation Rate at hprt (units = mutations/hprt locus/generation)

Cell line Rate (x 10-7) AA8AA8 7 ± 1 KO40KO40 ((fancgfancg)) <2.0 ± .3 ( >3x) BP6BP6 4 ± 1 HR mutants have increased mutation rate

Mutation Rate at hprt Cell line Rate (x 10-7) AA8AA8 77 ±± 11 51D1Lox51D1Lox 5.05.0 ±± .6.6 51D151D1 ((rad51drad51d)) 9090 ±± 2020 (( ~12x)~12x) irs1SFirs1SF ((xrcc3xrcc3)) 220220 ±± 5050 (( ~28x)~28x) 51D1.351D1.3 6.8 ± .8 Hprt mutation spectra

AA8AA8 == ~70%~70% pointpoint mutationsmutations KO40KO40 ((fancgfancg)) == largelarge deletiondeletion (1(1 clone)clone)

51D151D1 ((rad51drad51d)) == allall deletionsdeletions (12(12 clones)clones) Role of FA and HR in mutagenesis?

Model involves replication forks and lesion bypass Replication forks bypassing a lesion: Trans-Lesion Synthesis (TLS)

M TLS

Outcome: possible point mutation Replication forks bypassing a lesion: Fork regression (Chicken foot structure)

HR

Outcome: no mutation Replication forks arresting at a lesion: Fork breakage and collapse

HR NHEJ Model: FA proteins in replication fork stability

TLS M Point HR mutations

HR No mutation NHEJ Few hprt mutants Model: FA proteins in replication fork stability Ub M D2 TLS Point HR mutations

HR No mutation NHEJ Few hprt mutants Model: HR proteins in replication fork stability Ub D2 TLS M Point HR mutations

HR No mutation NHEJ MORE hprt mutants Acknowledgements

Larry Thompson Robert Tebbs Vicki Kopf Eddie Salazar Salustra Urbin Peter Nham